SPY381.72-1.91 -0.50%
DIA318.25+3.01 0.95%
IXIC12,609.16-310.99 -2.41%

Continued Level of Significant Insider Selling at Abiomed (ABMD)

· 02/04/2021 17:24

10:19 PM EST, 02/04/2021 (MT Newswires) -- A substantial insider sale of the shares of Abiomed was indicated in a form 4 document filed with the SEC today, showing -- Dorothy E Puhy, Director -- disposed of 5,000 shares in the company having a market value of approximately $1,747,347. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 13,656 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 18,656 shares and have averaged 6,219 shares per transaction over this time period.

The number of insider buy/sell trades at Abiomed is above that of the 100 peer company average over the last 90-day period. The Advanced Medical Equipment & Technology peer group saw 147 buy/sell trades during this period for an average of 1.5 transactions per company. However, the number of shares traded per transaction by Abiomed insiders is lower than its peers. Within the peer group there were 599,893 shares purchased and 5,192,931 shares sold with company insiders selling 31,245 shares on average over this time period.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to evaluate and write this story.

[Disclaimer]
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.